Diabetes diagnosis, resource utilization, and health outcomes

American Journal of Managed Care

Volumn 14, Issue 1, 2008, Pages 32-38

  Gulliford, Martin C ^a   Latinovic, Radoslav ^a   Charlton, Judith ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EMERGENCY CARE; FEMALE; HEALTH CARE; HEALTH CARE UTILIZATION; HOSPITAL CARE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; COST-BENEFIT ANALYSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DRUG UTILIZATION; EMERGENCY MEDICAL SERVICES; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HEALTH CARE SURVEYS; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; REGRESSION ANALYSIS;

EID: 38349189496     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
2. Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007;334:e299.
3. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 2004;27(suppl 1):S11-S14.
4. Gulliford MC, Charlton J, Latinovic R. Increased utilization of primary care five years before diagnosis of type 2 diabetes: a matched cohort study. Diabetes Care. 2005;28:47-52.
5. Nichols GA, Glauber HS, Brown JB. Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care. 2000;23:1654-1659.
6. Icks A, Haastert B, Giani G, Rathmann W. Incremental prescription and drug costs during the years preceding diabetes diagnosis in primary care practices in Germany. Exp Clin Endocrinol Diabetes. 2006;114:348-355.
7. Hubbard R, Lewis S, West J, et al. Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network. Thorax. 2005;60:848-850.
8. Tata LJ, Fortun PJ, Hubbard RB, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal antiinflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther. 2005;22:175-181.
9. NHS Information Authority. Clinical Terms (Read Codes): Summarised Product Description. Birmingham, England: NHS Information Authority; 2004.
10. StataCorp LP. STATA Statistical Software, Release 9. College Station, TX: StataCorp LP; 2006.
11. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
12. Kohner EM, Aldington SJ, Stratton IM, et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol. 1998;116:297-303.
13. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15:815-819.
14. Centers for Disease Control and Prevention (CDC). Prevalence of diabetes and impaired fasting glucose in adults: United States, 1999-2000. MMWR Morb Mortal Wkly Rep. 2003;52:833-837.
15. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care. 2002;25:1129-1134.
16. Rijkelijkhuizen JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDA, Dekker JM. High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn Study. Diabetes Care. 2007;30:332-336.
17. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
18. Gulliford MC, Latinovic R, Charlton J, Hughes RAC. Increased incidence of carpal tunnel syndrome up to 10 years before diabetes diagnosis. Diabetes Care. 2006;29:1929-1930.
19. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1999;310:555-559.
20. Rimm EB, Manson JE, Stampfer MJ, et al. Cigarette smoking and the risk of diabetes in women. Am J Public Health. 1993;83:211-214.
21. Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ. 1995;310:560-564.
22. McLaren L. Socioeconomic status and obesity. Epidemiol Rev. 2007;29:29-48.
23. Connolly V, Unwin N, Sherriff P, Bilous R, Kelly W. Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. J Epidemiol Community Health. 2000;54:173-177.
24. van Doorslaer E, Wagstaff A, van der Burg H, et al. Equity in the delivery of health care in Europe and the US. J Health Econ. 2000;19:553-583.
25. Neubauer S, Welte R, Beiche A, Koenig HH, Buesch K, Leidl R. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Tob Control. 2006;15:464-471.
26. Waugh N, Scotland G, McNamee P, et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess. 2007;11:1-144.